acetylcysteine has been researched along with Bone Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandi, ML; Fontani, F; Iantomasi, T; Marcucci, G; Vincenzini, MT | 1 |
Chen, CW; Cummins, JH; Gao, X; Huard, J; Li, H; Lu, A; Tang, Y; Tebbets, JC; Usas, A; Wang, B | 1 |
2 other study(ies) available for acetylcysteine and Bone Diseases
Article | Year |
---|---|
Glutathione, N-acetylcysteine and lipoic acid down-regulate starvation-induced apoptosis, RANKL/OPG ratio and sclerostin in osteocytes: involvement of JNK and ERK1/2 signalling.
Topics: Acetylcysteine; Adaptor Proteins, Signal Transducing; Animals; Antioxidants; Apoptosis; Bone Diseases; Bone Remodeling; Cell Line; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Glutathione; Glycoproteins; Hydrogen Peroxide; Intercellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; Mice; Necrosis; Osteocytes; Osteoprotegerin; Oxidation-Reduction; Phosphorylation; RANK Ligand; Thioctic Acid | 2015 |
BMP2 is superior to BMP4 for promoting human muscle-derived stem cell-mediated bone regeneration in a critical-sized calvarial defect model.
Topics: Acetylcysteine; Adult; Aged, 80 and over; Animals; Biomarkers; Bone Diseases; Bone Morphogenetic Protein 4; Bone Regeneration; Cell Survival; Cells, Cultured; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Nude; Mice, SCID; Muscle, Skeletal; Osteogenesis; Stem Cell Transplantation; Stem Cells; Transplantation, Heterologous; Young Adult | 2013 |